The integrative multi-omics approach identifies the novel competing endogenous RNA (ceRNA) network in colorectal

Ghanbar Mahmoodi Chalbatani1, Elahe Gharagouzloo1,2, Mohammad Amin Malekraeisi3

  • 1Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Science, Tehran, Iran.

Scientific Reports
|November 9, 2023
PubMed

Insights

Circular RNAs (circRNAs) act as competing endogenous RNAs (ceRNAs) in colorectal cancer (CRC). This study identifies hsa_circ_000240 as a key circRNA, revealing its role in CRC progression through interactions with specific genes like CDC6 and ORC1, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Circular RNAs (circRNAs) are recognized regulators in cancer via competing endogenous RNA (ceRNA) mechanisms involving microRNAs (miRNAs).
  • The specific role of circ000240, its miRNA interactions, and mRNA targets in colorectal cancer (CRC) pathogenesis remains unclear.

Purpose of the Study:

  • To elucidate the pathological function of the hsa_circ_000240/miRNA/mRNA axis in colorectal cancer (CRC).
  • To identify key genes and regulatory pathways involved in CRC progression and their association with patient survival and immune cell infiltration.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to assess hsa_circ_000240 expression in CRC tissues.
  • Bioinformatic analyses including network topology, microarray, bulk RNA sequencing, and single-cell RNA sequencing (scRNA-seq) to identify miRNA-mRNA interactions and hub genes.
  • ATAC-seq and methylation analysis to investigate epigenetic modifications associated with candidate genes.

Main Results:

  • hsa_circ_000240 was significantly upregulated in CRC tissues.
  • Identification of three interacting miRNAs and 1680 downstream target genes, with network analysis pinpointing 33 hub genes, including CDC6 and ORC1, which significantly impact overall survival.
  • scRNA-seq and ATAC-seq confirmed elevated CDC6 and ORC1 expression in CRC, linked to immune cell infiltration, chromatin accessibility, and epigenetic modifications like histone acetylation and promoter methylation.

Conclusions:

  • hsa_circ_000240 functions as a ceRNA in CRC, influencing cancer progression through the CDC6 and ORC1 axis.
  • The findings highlight novel epigenetic regulatory mechanisms and identify CDC6 and ORC1 as potential therapeutic targets for CRC immunotherapy.